Oncology

Unfortunately, the generally accepted modern protocols for the treatment of malignant tumours do not always give the expected results. Moreover, in many cases, the toxicity of the drugs and procedures used for treatment has an additional negative effect on the weakened body of the patient.

The development of next-generation drugs is actively underway worldwide.

Some progress has been made in the use of new cytotoxic and cytostatic drugs aimed at destroying tumour cells and/or suppressing their proliferative activity.

Cytostatic drugs (cytostatics) are anticancer drugs aimed at suppressing the growth, development and division of all cell types, including malignant, and, thus, they trigger apoptosis.

Cytostatic drugs are mainly used in cancer treatment (to treat malignant tumors).

Anti-tumour drug CR 173487 was created by using the unique technology developed as a result of more than 20 years of scientific and medical research. 

The drug belongs to a class of drugs called Cytostatics.